软坚消瘿汤治疗慢性淋巴细胞性甲状腺炎的临床疗效

薛云芳

（陕西省宜川县疾病预防控制中心，陕西 延安，716200）

浏览次数：129次 下载次数：400次

摘要：

目的 探讨软坚消瘿汤治疗慢性淋巴细胞性甲状腺炎的临床疗效。方法 选取我院2014年3月至2015年4月收治的慢性淋巴细胞性甲状腺炎疾病患者124例为研究对象，根据入院顺序分为对照组和研究组，各62例。对照组患者采用西药治疗，研究组患者采用中药软坚消瘿汤进行治疗，对比两组患者的临床疗效。结果 研究组患者的治疗总有效率为95.16%，明显高于对照组的82.26%，差异具有统计学意义（P <0.05）。治疗后，研究组患者的TMAb、TGAb、FT4、FT3水平明显优于对照 组，差异具有统计学意义（P<0.05）；两组患者的TSH指数比较，差异无统计学意义（P>0.05）。结论 临床治疗慢性淋巴细胞性甲状腺炎疾病时，可考虑将软坚消瘿汤方式作为首选方式之一，疗效显著，各临床指标得到了显著改善，具有较大的临床应用及推广价值。

关键词：慢性淋巴细胞性甲状腺炎；软坚消瘿汤；甲状腺球蛋白抗体

中图分类号：R259文献标志码：A文章编号：2096-1413(2017)09-0089-02

Clinical effect of Ruanjian Xiaoying decoction on chronic lymphocytic thyroiditis
XU Yun-fang
(Centers for Disease Control and Prevention of Yichuan County, Yan'an 716200, China)

ABSTRACT: Objective To study the clinical effect of Ruanjian Xiaoying decoction on chronic lymphocytic thyroiditis.Methods One hundred and twenty-four cases of patients with chronic lymphocytic thyroiditis admitted in our hospital from March 2014 to April 2015 were selected as the study objects. All the patients were divided into control group and study group according to the admission order, with 62 cases in each group. The control group received western medicine, while the study group accepted Ruanjian Xiaoying decoction. The clinical effect of two groups were compared. Results The total effective rate of the study group was 95.16%, which was higher than 82.26% of the control group (P<0.05). After treatment, the levels of TMAb, TGAb, FT4 and FT3 of the study group were better than those of the control group (P<0.05); there was no significant difference on TSH of two groups (P<0.05). Conclusion Ruanjian Xiaoying decoction can be considered as one of the best treatment to chronic lymphocytic thyroiditis, its clinical effect is significant, and the clinical indexes can be improved significantly. It is worthy of clinical promotion value.
KEYWORDS: chronic lymphocytic thyroiditis; Ruanjian Xiaoying decoction; thyroglobulin antibodies

参考文献：
[1] 邵华强,张晨晨,管琳,等.桥本氏甲状腺炎与弥漫性甲状腺肿的超声特点及其中医证型分析[J].中国中西医结合影像学杂志,2014,12(5):452-454.
[2] 王士旭,佘志强,安常明,等.淋巴细胞性甲状腺炎合并甲状腺乳头状癌的临床分析[J].中华耳鼻咽喉头颈外科杂志,2016,51(4):277-281.

[3] 苏有玲,耿峰.基于Markov 模型评价疏肝健脾中药干预桥本式甲状腺炎远期疗效的研究[J].中医临床研究,2015,7(28):8-10.
[4] 黄琦,冯晓红,张寅晓,等.人参皂苷对实验性自身免疫性甲状腺炎大鼠Th1/Th2 相关细胞因子的影响[J].中医杂志,2013,54(24):2132-2134.
[5] 汪德芬,裴瑞霞,高上林,等.高上林主任医师治疗亚急性甲状腺炎的临床经验[J].陕西中医,2013,34(8):1027-1029.
[6] 张育瑛,夏鸣喆,李艺,等.隔附子饼灸对桥本氏甲状腺炎血清特异抗体与甲状腺功能的相关性分析[J].上海针灸杂志,2013,32(1):25-27.

[7] 匡瑞娟,高兰美,杨春霞,等.硒酵母与左旋甲状腺素联合应用治疗淋巴细胞性甲状腺炎的随机对照分析[J].国际医药卫生导报,2015,21(12):1714-1716.
[8] 曹拥军,李靖,刘钧,等.穿山龙对甲状腺功能减退的桥本甲状腺炎患者影响的研究[J].中国全科医学,2013,16(27):2486-2488.
[9] 张兰,邹晓宁,姜维娜,等.含碘中药复方对AIT大鼠甲状腺组织凋亡调控蛋白Fas、FasL、Bcl-2、Bax的影响[J].中药新药与临床药理,2013,24(2):159-162.
[10] 陈志英,王有贵,孟和宝力高,等.中医药对产后甲状腺炎综合诊疗的研究进展简述[J].中国煤炭工业医学杂志,2013,16(3):505-506.